Contrast-enhanced ultrasonography for blood flow detection in hepatocellular carcinoma during lenvatinib therapy.
Naoki MatsumotoMasahiro OgawaMasahiro KanekoShuhei ArimaMariko KumagawaYukinobu WatanabeMidori HirayamaRyota MasuzakiTatsuo KandaMitsuhiko MoriyamaPublished in: Journal of medical ultrasonics (2001) (2022)
The viability of the HCC should be confirmed using CEUS when contrast-enhanced CT/MRI reveals lesion hypoenhancement during lenvatinib therapy.